Login

Corline Biomedical - Naventus Healthcare Summit, May 10, 2022 - Henrik Nittmar, CEO at Corline Biomedical 00:00:00

Share On Facebook Share On Twitter

Corline Biomedical - Naventus Healthcare Summit, May 10, 2022

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating Market Volatility: Insights from Russ Brownback on Fixed Income Strategies
00:10:00
Exploring the Future of Nuclear Power: Uranium Opportunities in Namibia and Australia
00:10:00
Transition Investing: Seizing Opportunities in Today's Economic Revolution | Lombard Odier Investment Managers
00:10:00
Microvision CEO Sumit Sharma asserts increased confidence in the company's pursuit of lidar market dominance.
00:10:00
Exceptional Ideas: James Gorman on Seizing the Moment and Transforming Morgan Stanley
00:10:00
First partner to exceptional teams and creative innovation|Luca Bocchio,Partner,Accel
00:10:00
Misbehaving: The Evolution of Behavioral Economics – A Conversation with Richard Thaler and Google's Chief Economist Hal Varian at Talks at Google
00:10:00
Strategic Investment Insights on Inflation and Real Assets
00:10:00
Great Southern Copper Unveils Major Copper-Gold System at San Lorenzo | Sam Garrett , CEO, Great Southern Copper PLC.
00:00:00
Research on several areas related to improving the health care system / Michael E. Chernew, PhD Leonard D. Schaeffer Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School; Director, Healthcare Markets and Regulation Lab
00:10:00
Investment Opportunities in the Canadian EV and Lithium Industry: Development, Exploration, and Downstream Potential
00:10:00
Grindrod Reports 26% Rise in Earnings, Records Record Port Volumes | Xolani Mbambo - CEO of Grindrod Limited

© 2026 Nehu